Could disease labelling have positive effects? An experimental study exploring the effect of the chronic fatigue syndrome label on intended social support. — CFSMEATLAS
Could disease labelling have positive effects? An experimental study exploring the effect of the chronic fatigue syndrome label on intended social support.
Noble, Samara, Bonner, Carissa, Hersch, Jolyn et al. · Patient education and counseling · 2019 · DOI
Quick Summary
This study asked university students how they would respond to a close friend who has ME/CFS, comparing situations where the condition was labeled as 'chronic fatigue syndrome' versus unlabeled. When the CFS label was used, students reported they would be more sympathetic, less rejecting, and more supportive of medical treatment for their friend. This suggests that having a recognized disease name might actually help people with ME/CFS receive better social support from their friends.
Why It Matters
ME/CFS patients frequently report inadequate social support, which can worsen symptoms and quality of life. This study provides evidence that formally naming the condition as 'chronic fatigue syndrome' may improve how friends perceive and support someone with ME/CFS, offering a potential benefit of disease labeling that is often overlooked in discussions about diagnosis and stigma.
Observed Findings
The CFS label elicited significantly higher sympathetic responses compared to no-label conditions.
The CFS label resulted in lower rates of rejecting responses from hypothetical friends.
Participants indicated greater support for active medical treatment when the CFS label was used.
Effects were significantly stronger in male participants than female participants.
No significant effect of labeling was found on intended behavioral support.
Inferred Conclusions
Disease labeling with 'chronic fatigue syndrome' may increase the potential for social support from friends.
Young adults, particularly men, develop more supportive attitudes toward a friend when a formal CFS diagnosis is present.
The effects of disease labels on social support potential warrant consideration when evaluating the overall usefulness and impact of diagnostic labels.
Remaining Questions
Do these hypothetical intended responses translate to actual behavioral support in real-world friendships with ME/CFS patients?
Why do male participants show significantly stronger supportive responses to the CFS label than female participants?
What This Study Does Not Prove
This study does not establish whether these intended responses would translate into actual behavioral support in real-life situations, since it was based on hypothetical scenarios rather than real interactions. It also does not examine how the CFS label affects support from family members, healthcare providers, or employers—only peers. The findings cannot be generalized beyond university-age populations or determine the long-term effects of labeling on support.